Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP3 | Q9NY33 | 5/20 | 0.64 |
| ▸ | KISS1R | Q969F8 | 4/20 | 0.61 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.53 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.53 |
| ▸ | CTSB | P07858 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34463648 | 0.93 | KISS1R (0.62) | DPP3KISS1RIL23RC5AR1 | |
| SCHEMBL30268594 | 0.93 | IL23R (0.66) | DPP3KISS1RIL23RC5AR1 | |
| SCHEMBL38661114 | 0.92 | KISS1R (0.62) | DPP3KISS1RIL23ROPRM1 | |
| SCHEMBL31071616 | 0.91 | DPP3 (0.73) | DPP3KISS1ROPRM1SLC6A2 | |
| SCHEMBL29804127 | 0.91 | DPP3 (0.73) | DPP3KISS1ROPRM1SLC6A2 | |
| SCHEMBL31307225 | 0.90 | IL23R (0.65) | KISS1RIL23RC5AR1 | |
| SCHEMBL19787869 | 0.89 | DPP3 (0.69) | DPP3OPRM1SLC6A2C5AR1CAPN1 | |
| SCHEMBL30392261 | 0.89 | DPP3 (0.61) | DPP3KISS1ROPRM1SLC6A2CAPN1 | |
| SCHEMBL31332280 | 0.89 | KISS1R (0.64) | KISS1RIL23RC5AR1 | |
| SCHEMBL31090175 | 0.89 | DPP3 (0.77) | DPP3KISS1ROPRM1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115244401-A | DPP3 for therapy guidance, monitoring and stratification of NT-ADM antibodies in shock patients | 4TEEN4制药有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-115769076-A | DPP3 in patients infected with coronaviruses | 4TEEN4制药有限公司 | 2023-03-07 | — | — | CN | disclosed |
| CN-115244401-A | DPP3 for therapy guidance, monitoring and stratification of NT-ADM antibodies in shock patients | 4TEEN4制药有限公司 | 2022-10-25 | — | — | CN | disclosed |